Scientists demonstrated that targeted inhibition of lysine-specific demethylase 1 (LSD1) in small cell lung cancer restored major histocompatibility complex (MHC) class I cell surface expression and transcriptionally activated genes encoding the antigen presentation pathway.
[Journal of Thoracic Oncology]
